ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAN PHILLIPS MD

Internal Medicine

470

$28.4K

143
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

47%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

CYRIL VARUGHESE D.O.

Internal Medicine

467

$23.1K

46
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

MELANIE SULISTIO M.D.

Internal Medicine

461

$19.2K

58
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $67

SHABAZ KHAN MD

Internal Medicine

461

$15.4K

189
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$33
Average prescription price

Avg: $67

MAURICIO RUIZ-BARON M.D.

Internal Medicine

455

$15.3K

155
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$34
Average prescription price

Avg: $67

SAURIN PATEL MD

Internal Medicine

451

$18K

42
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $67

JOHN LACSON MD

Internal Medicine

450

$27.8K

117
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

COURTNEY MCCRAY MD

Internal Medicine

449

$94.2K

72
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$210
Average prescription price

Avg: $67

MEGAN SHAW M.D.

Internal Medicine

442

$14.7K

31
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$33
Average prescription price

Avg: $67

KATHRYN BROWN MD

Internal Medicine

439

$26.9K

125
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

ALFREDO VAZQUEZ M.D.

Internal Medicine

432

$62.9K

73
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 27%

$146
Average prescription price

Avg: $67

CYNTHIA SAVAGE MD

Internal Medicine

430

$15.3K

182
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 27%

$36
Average prescription price

Avg: $67

DAMODHARAN VAIDYANATHAN M.D

Internal Medicine

426

$14.2K

114
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$33
Average prescription price

Avg: $67

ALAN CARPENTER D.O.

Internal Medicine

424

$8,238

222
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$19
Average prescription price

Avg: $67

JAMES LOVERDE M.D.

Internal Medicine

422

$19.3K

166
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

JOSEPH PRANULIS MD

Internal Medicine

420

$5,911

240
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

5%
prescriptions for brand name drugs

Avg: 27%

$14
Average prescription price

Avg: $67

CHARU SAWHNEY DO

Internal Medicine

407

$30.7K

34
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

JAI JADEGONDANAHALLI M.D.

Internal Medicine

397

$22.1K

143
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

ABDUL RAHIMAN MD

Internal Medicine

392

$16.2K

157
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$41
Average prescription price

Avg: $67

SRILATHA VELLANKI MD

Internal Medicine

391

$15.5K

180
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $67

DARSHAN GANDHI M.B.B.S.

Internal Medicine

388

$28.5K

69
51 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

AMAL MELHEM-BERTRANDT M.D.

Internal Medicine

386

$126K

68
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$326
Average prescription price

Avg: $67

JOSE SANDOVAL MD

Internal Medicine

384

$20.6K

32
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

THAI HUYNH MD

Internal Medicine

384

$14K

99
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$36
Average prescription price

Avg: $67

CYNTHIA LAN MD

Internal Medicine

382

$326K

92
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$854
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank